Researchers announced results of a new study which demonstrated that smartphone-based mHealth devices, coupled with handheld echocardiography, can provide improved assessment and are readily integrated at the point-of-care for evaluation of patients with structural heart diseases. This study was conducted as part of the American Society of Echocardiography (ASE) Foundation's Valvular Assessment Leading to Unexplored Echocardiographic Stratagems (VALUES) program, a four-day teaching and research event held at the Sri Sathya Sai Institute of Higher Medical Sciences in Bangalore, India, August 11-14, 2014. Over the course of several days, researchers assessed patients with multiple forms of rheumatic valvular heart disease with either standard diagnostic equipment or mobile health-based devices.

June 12, 2015 — Fujifilm Medical Systems U.S.A. Inc. will demonstrate the latest generation of Synapse Cardiovascular version 6.0 at the American Society of Echocardiography (ASE) 26th Annual Scientific Sessions, June 13 – 15 in Boston. Synapse Cardiovascular version 6.0 is a total re-engineering of Fujifilm’s solution for echo reporting.

The latest advances in cardiovascular echocardiography will be presented at the 2015 American Society of Echocardiography (ASE) annual meeting June 12-16 in Boston. Several companies are making big announcements about new software and hardware.

Researchers announce the results of an early study that shows a fused fluoroscopic/ echocardiographic imaging (FFEI) system is feasible and provides improved guidance of interventional procedures in pediatric patients with congenital heart disease. An estimated 40,000 children are born in the United States each year with various forms of Congenital Heart Disease, with at least a quarter of those requiring some type of surgical intervention. The study is being presented at the 2015 American Society of Echocardiography (ASE) June 12- 16, in Boston.

 

Endovascular treatment (EVT) of intracranial aneurysm is effective in preventing long-term bleeding, but may be followed by aneurysm recurrences in a significant proportion of cases, according to a study published online in the journal Radiology.


Breakthrough Research Demonstrates Contrast Ultrasound Can be Used as Heart Attack Treatment 


At the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 6-10 at the Baltimore Convention Center, Siemens Healthcare debuted new technologies designed to expand the capabilities and improve the productivity of molecular imaging. Symbia Evo, Siemens’ new single-photon emission computed tomography (SPECT) system, boosts user productivity, providing facilities with more time to plan treatment schedules, personalize studies, serve additional patients and improve workflow efficiency.

Subscribe Now